FGF10 alleviates acute lung injury by inhibiting AMPK‐RIPK1/caspase‐8/caspase‐3/GSDME‐mediated pyroptosis in AECs primed by distinct immune cell populations, supporting its potential as a therapeutic strategy for ARDS. This evidence concerns the gene GSDME and acute respiratory distress syndrome.